Recent publications on Cancer

White LL, Burnett-Hartman AN, Ichikawa LE, Goldberg SR, Chubak J, Spencer Feigelson H, Kamineni A. SARS-CoV-2 infection and related hospitalization among cancer survivors. Cancer Epidemiol Biomarkers Prev. 2023 Dec 21. doi: 10.1158/1055-9965.EPI-23-1303. [Epub ahead of print]. PubMed

Aiello Bowles EJ, Kroenke CH, Chubak J, Bhimani J, O'Connell K, Brandzel S, Valice E, Doud R, Theis MK, Roh JM, Heon N, Persaud S, Griggs JJ, Bandera EV, Kushi LH, Kantor ED. Evaluation of algorithms using automated health plan data to identify breast cancer recurrences. Cancer Epidemiol Biomarkers Prev. 2023 Dec 13. doi: 10.1158/1055-9965.EPI-23-0782. [Epub ahead of print]. PubMed

Kerlikowske K, Chen S, Bissell MCS, Lee CI, Tice JA, Sprague BL, Miglioretti DL. Population attributable risk of advanced-stage breast cancer by race and ethnicity. JAMA Oncol. 2023 Dec 7:e235242. doi: 10.1001/jamaoncol.2023.5242. [Epub ahead of print]. PubMed

Winer RL, Lin J, Anderson ML, Tiro JA, Green BB, Gao H, Meenan RT, Hansen K, Sparks A, Buist DSM. Strategies to increase cervical cancer screening with mailed human papillomavirus self-sampling kits: A randomized clinical trial. JAMA. 2023 Nov 28;330(20):1971-1981. doi: 10.1001/jama.2023.21471. PubMed

Atakpa EC, Buist DSM, Bowles EJA, Cuzick J, Brentnall AR. Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: A cohort study. Breast Cancer Res. 2023 Nov 24. doi:10.1186/s13058-023-01744-y. Online ahead of print. PubMed

Gard CC, Tice JA, Miglioretti DL, Sprague BL, Bissell MCS, Henderson LM, Kerlikowske K. Extending the Breast Cancer Surveillance Consortium model of invasive breast cancer. J Clin Oncol. 2023 Nov 17:JCO2202470. doi: 10.1200/JCO.22.02470 [Epub ahead of print] PubMed

Liu PH, Nair RG, Skinner CS, Murphy CC, Kim EJ, Ortiz C, Wang L, Hu E, Lykken JM, Levin TR, Green BB, Hahn EE, Santini N, Halm EA. Unsatisfactory fecal immunochemical tests for colorectal cancer screening: prevalence, reasons, and subsequent testing. Cancer Epidemiol Biomarkers Prev. 2023 Nov 15:OF1-OF9. doi: 10.1158/1055-9965.EPI-23-0507. Online ahead of print. PubMed

Mandelblatt JS, Schechter CB, Stout NK, Huang H, Stein S, Hunter Chapman C, Trentham-Dietz A, Jayasekera J, Gangnon RE, Hampton JM, Abraham L, O'Meara ES, Sheppard VB, Lee SJ. Population simulation modeling of disparities in US breast cancer mortality.  J Natl Cancer Inst Monogr. 2023;2023(62):178-187. doi: 10.1093/jncimonographs/lgad023.  PubMed

Kantor ED, O’Connell KO, Ergas IJ, Valice E, Roh JM, Bhimani J, Heon N, Griggs JJ, Lee J, Bowles EJA, Rivera DR, Kolevska T, Bandera EV, Kushi LH. Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system. Breast Cancer Res Treat. 2023 Nov 4. doi: 10.1007/s10549-023-07126-4. Online ahead of print. PubMed

Kerlikowske K, Zhu W, Su YR, Sprague BL, Stout NK, Onega T, O'Meara ES, Henderson LM, Tosteson ANA, Wernli K, Miglioretti DL. Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density. J Natl Cancer Inst. 2023 Oct 27:djad201. doi: 10.1093/jnci/djad201. [Epub ahead of print]. PubMed

Thomas M, Su YR, Rosenthal EA, Sakoda LC, Schmit SL, Timofeeva MN, Chen Z, Fernandez-Rozadilla C, Law PJ, Murphy N, Carreras-Torres R, Diez-Obrero V, van Duijnhoven FJB, Jiang S, Shin A, Wolk A, Phipps AI, Burnett-Hartman A, Gsur A, Chan AT, Zauber AG, Wu AH, Lindblom A, Um CY, Tangen CM, Gignoux C, Newton C, Haiman CA, Qu C, Bishop DT, Buchanan DD, Crosslin DR, Conti DV, Kim DH, Hauser E, White E, Siegel E, Schumacher FR, Rennert G, Giles GG, Hampel H, Brenner H, Oze I, Oh JH, Lee JK, Schneider JL, Chang-Claude J, Kim J, Huyghe JR, Zheng J, Hampe J, Greenson J, Hopper JL, Palmer JR, Visvanathan K, Matsuo K, Matsuda K, Jung KJ, Li L, Le Marchand L, Vodickova L, Bujanda L, Gunter MJ, Matejcic M, Jenkins MA, Slattery ML, D'Amato M, Wang M, Hoffmeister M, Woods MO, Kim M, Song M, Iwasaki M, Du M, Udaltsova N, Sawada N, Vodicka P, Campbell PT, Newcomb PA, Cai Q, Pearlman R, Pai RK, Schoen RE, Steinfelder RS, Haile RW, Vandenputtelaar R, Prentice RL, Küry S, Castellví-Bel S, Tsugane S, Berndt SI, Lee SC, Brezina S, Weinstein SJ, Chanock SJ, Jee SH, Kweon SS, Vadaparampil S, Harrison TA, Yamaji T, Keku TO, Vymetalkova V, Arndt V, Jia WH, Shu XO, Lin Y, Ahn YO, Stadler ZK, Guelpen BV, Ulrich CM, Platz EA, Potter JD, Li CI, Meester RR, Moreno V, Figueiredo JC, Casey G, Vogelaar IL, Dunlop MG, Gruber SB, Hayes RB, Pharoah PD, Houlston RS, Jarvik GP, Tomlinson IP, Zheng W, Corley DA, Peters U, Hsu L. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations.  Nat Commun. 2023;14(1):6147. doi: 10.1038/s41467-023-41819-0.  PubMed

Hahn EE, Staab J, Munoz-Plaza C, Gander J, Kushi L, McMullin C, Oshiro C, Wernli KJ, Ritzwoller D. Incidence and survival for breast, colorectal and lung cancer patients in an integrated system. Perm J. 2023 Sep 19;1-7. doi: 10.7812/TPP/23.021. Online ahead of print. PubMed

Onega T, Abraham L, Miglioretti DL, Lee CI, Henderson LM, Kerlikowske K, Tosteson ANA, Weaver D, Sprague BL, Bowles EJA, di Florio-Alexander RM. Digital mammography and digital breast tomosynthesis for detecting invasive lobular and ductal carcinoma. Breast Cancer Res Treat. 2023 Dec;202(3):505-514. doi: 10.1007/s10549-023-07051-6. Epub 2023 Sep 11. PubMed

Alimena S, Lykken JM, Tiro JA, Chubak J, Kamineni A, Haas JS, Werner C, Kobrin SC, Feldman S. Timing of colposcopy and risk of cervical cancer. Obstet Gynecol. 2023 Nov 1;142(5):1125-1134. doi: 10.1097/AOG.0000000000005313. Epub 2023 Aug 21. PubMed

Lee JM, Ichikawa LE, Wernli KJ, Bowles EAJ, Specht JM, Kerlikowske K, Miglioretti DL, Lowry KP, Tosteson ANA, Stout NK, Houssami N, Onega T, Buist DSM. Impact of surveillance mammography intervals less than one year on performance measures in women with a personal history of breast cancer. J Korean Radiol. 2023 Aug;24(8):729-738. doi: 10.3348/kjr.2022.1038. PubMed

Dimou N, Kim AE, Flanagan O, Murphy N, Diez-Obrero V, Shcherbina A, Aglago EK, Bouras E, Campbell PT, Casey G, Gallinger S, Gruber SB, Jenkins MA, Lin Y, Moreno V, Ruiz-Narvaez E, Stern MC, Tian Y, Tsilidis KK, Arndt V, Barry EL, Baurley JW, Berndt SI, Bézieau S, Bien SA, Bishop DT, Brenner H, Budiarto A, Carreras-Torres R, Cenggoro TW, Chan AT, Chang-Claude J, Chanock SJ, Chen X, Conti DV, Dampier CH, Devall M, Drew DA, Figueiredo JC, Giles GG, Gsur A, Harrison TA, Hidaka A, Hoffmeister M, Huyghe JR, Jordahl K, Kawaguchi E, Keku TO, Larsson SC, Le Marchand L, Lewinger JP, Li L, Mahesworo B, Morrison J, Newcomb PA, Newton CC, Obon-Santacana M, Ose J, Pai RK, Palmer JR, Papadimitriou N, Pardamean B, Peoples AR, Pharoah PDP, Platz EA, Potter JD, Rennert G, Scacheri PC, Schoen RE, Su YR, Tangen CM, Thibodeau SN, Thomas DC, Ulrich CM, Um CY, van Duijnhoven FJB, Visvanathan K, Vodicka P, Vodickova L, White E, Wolk A, Woods MO, Qu C, Kundaje A, Hsu L, Gauderman WJ, Gunter MJ, Peters U. Probing the diabetes and colorectal cancer relationship using gene - environment interaction analyses. Br J Cancer. 2023 Aug;129(3):511-520. doi: 10.1038/s41416-023-02312-z. Epub 2023 Jun 26. PubMed

Knerr S, Guo B, Wernli KJ, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Liles EG, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Wilfond BS, Devine B, Goddard KAB. Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system. Breast Cancer Res Treat. 2023 Oct;201(3):461-470. doi: 10.1007/s10549-023-07007-w. Epub 2023 Jul 20. PubMed

Sung H, Hyun N, Ohman RE, Yang EH, Siegel RL, Jemal A. Mediators of Black-White inequities in cardiovascular mortality among survivors of 18 cancers in the USA. Int J Epidemiol. 2023 Jul 20;dyad097. doi: 10.1093/ije/dyad097. Online ahead of print. PubMed

Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Burnett-Hartman AN, Corley DA, Doria-Rose VP, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J. Risk of colorectal cancer and colorectal cancer mortality beginning one year after a negative fecal occult blood test, among screen-eligible 76-85-year-olds. Cancer Epidemiol Biomarkers Prev. 2023 Oct 2;32(10):1382-1390. doi: 10.1158/1055-9965.EPI-23-0265. PubMed

Nyante SJ, Abraham L, Aiello Bowles EJ, Lee CI, Kerlikowske K, Miglioretti DL, Sprague BL, Henderson LM. Racial and ethnic variation in diagnostic mammography performance among women reporting a breast lump. Cancer Epidemiol Biomarkers Prev. 2023 Jul 13:EPI-23-0289. doi: 10.1158/1055-9965.EPI-23-0289. [Epub ahead of print]. PubMed